Advertisement
Advertisement
GEHC
GE HealthCare Technologies Inc. Common Stock
62.67
USDSponsored
+0.78
+1.26%
May 14, 16:00 UTC -4
Closed
After-Market
62.47
-0.20
-0.33%
GEHC Earnings Reports
Positive Surprise Ratio
GEHC beat 10 of 13 last estimates.
77%
Next Report
Date of Next Report
Jul 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
$5.38B
/$1.05
Implied change from Q1 26 (Revenue/ EPS)
+4.76%
/+6.06%
Implied change from Q2 25 (Revenue/ EPS)
+7.36%
/-0.94%
GE HealthCare Technologies Inc. Common Stock earnings per share and revenue
On Apr 29, 2026, GEHC reported earnings of 0.99 USD per share (EPS) for Q1 26, missing the estimate of 1.07 USD, resulting in a -7.55% surprise. Revenue reached 5.13 billion, compared to an expected 5.14 billion, with a -0.13% difference. The market reacted with a -13.16% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of 1.05 USD, with revenue projected to reach 5.38 billion USD, implying an increase of 6.06% EPS, and increase of 4.76% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Prestige Consumer Healthcare Inc.
Report Date
May 13, 2026 For Q4 26
Estimate
$1.40
Actual
$1.23
Surprise
-12.39%
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
$0.12
Actual
$0.18
Surprise
+45.28%
Omeros Corporation
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+26.47%
Brainsway Ltd. - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
$0.17
Actual
$0.12
Surprise
-31.35%
Valneva SE - ADR
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.35
Surprise
-407.45%
TriSalus Life Sciences, Inc. Common Stock
Report Date
May 12, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.14
Surprise
+12.01%
MacroGenics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.58
Actual
-$0.57
Surprise
+0.45%
Immucell Corp
Report Date
May 14, 2026 For Q1 26
Estimate
-Actual
$0.21
Surprise
-
Cytosorbents Corp.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.08
Surprise
-42.60%
Bonk, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.23
Surprise
-
FAQ
What were GE HealthCare Technologies Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, GE HealthCare Technologies Inc. Common Stock reported EPS of $0.99, missing estimates by -7.55%, and revenue of $5.13B, -0.13% below expectations.
How did the market react to GE HealthCare Technologies Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -13.16%, changed from $68.50 before the earnings release to $59.48 the day after.
When is GE HealthCare Technologies Inc. Common Stock expected to report next?
The next earning report is scheduled for Jul 27, 2026.
What are the forecasts for GE HealthCare Technologies Inc. Common Stock's next earnings report?
Based on --
analysts, GE HealthCare Technologies Inc. Common Stock is expected to report EPS of $1.05 and revenue of $5.38B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement